Amendment to Memorandum of Understanding between Vitro Diagnostics, Inc. and Caribbean GC Development Fund
Vitro Diagnostics, Inc. and Caribbean GC Development Fund have agreed to amend their original Memorandum of Understanding dated February 22, 2017. This amendment extends the closing date for a debt investment to May 31, 2017. All other terms and conditions of the original agreement remain unchanged. The amendment is effective as of April 14, 2017, and is signed by authorized representatives of both parties.
AMENDMENT TO MEMORANDUM OF UNDERSTANDING
THIS AMENDMENT TO MEMORANDUM OF UNDERSTANDING (this “Amendment”) is made and entered into as of the 14th day of April, 2017 by and between Vitro Diagnostics, Inc. (the “Company”) and Caribbean GC Development Fund (“GC”).
W I T N E S S E T H:
WHEREAS, the Company GC entered into a Memorandum of Understanding dated February 22, 2017 (the “MOU”); and
WHEREAS, the Company and GC desire to modify and amend the MOU and desire to set forth their agreement in writing.
NOW, THEREFORE, for and in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and GC agree that the MOU shall be modified and amended in the following respects.
1.
The Closing Date set for the Debt Investment is extended to May 31, 2017.
2.
All other terms and conditions set forth in the MOU shall remain in full force and effect.
IN WITNESS WHEREOF, Company and GC have caused this Amendment to be executed as of the date first written hereinabove.
VITRO DIAGNOSTICS, INC.
By:
/s/ James R. Muscik
Name:
James R. Musick, Ph.D.
Title:
President and CEO
CARIBBEAN GC DEVELOPMENT FUND
By:
/s/ William W. Becker
Name:
William W. Becker
Title:
CEO
1
HNZW/501147_1.docx/4232-1
